Literature DB >> 10702263

Phosphorylation of the membrane proximal region of tumor necrosis factor receptor CD120a (p55) at ERK consensus sites.

A A Van Linden1, V Cottin, C Leu, D W Riches.   

Abstract

The interaction of tumor necrosis factor-alpha with its receptor CD120a (p55) initiates downstream signaling cascades that include the activation of the mitogen-activated protein kinase (MAPK), p42(mapk/erk2). The membrane proximal region of CD120a (p55) is Ser-, Thr-, and Pro-rich and contains four mitogen-activated protein kinase consensus phosphorylation sites. In recent work, we showed that CD120a (p55) itself is a target of phosphorylation by p42(mapk/erk2), and after phosphorylation, the receptor is redistributed from the cell surface and Golgi complex to intracellular tubular structures associated with elements of the endoplasmic reticulum. The goal of this study was to define the specific amino acid residues that are phosphorylated. Deletional mutagenesis of the cytoplasmic domain of CD120a (p55) indicated that two sites located between residues 207-254 and 250-300 were phosphorylated predominantly on Thr and Ser residues, respectively. Site-directed mutagenesis of Ser and Thr residues contained within the extracellular signal-regulated kinase (ERK) consensus sequences indicated that the preferred residues were Thr-236 and Ser-270. Primary phosphorylation at these sites appeared to enable subsequent phosphorylation at Ser-240 and Ser-244, although the level of phosphorylation of these latter two sites was less than the preferred sites. Through the use of specific ligation of CD120a (p55) alone and mice deficient in CD120a (p55), CD120b (p75), or both receptors, CD120a (p55) was shown to be necessary and sufficient for the induction of kinase activity. These findings thus suggest that the phosphorylation of Thr-236 and Ser-270 within the membrane proximal region of CD120a (p55) are the preferred sites of phosphorylation by p42(mapk/erk2) and may set in motion phosphorylation at other sites.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702263     DOI: 10.1074/jbc.275.10.6996

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  MEK Inhibition Modulates Cytokine Response to Mediate Therapeutic Efficacy in Lung Cancer.

Authors:  Mengyu Xie; Hong Zheng; Ranjna Madan-Lala; Wenjie Dai; Nicholas T Gimbrone; Zhihua Chen; Fumi Kinose; Sarah A Blackstone; Keiran S M Smalley; W Douglas Cress; Eric B Haura; Uwe Rix; Amer A Beg
Journal:  Cancer Res       Date:  2019-07-30       Impact factor: 12.701

2.  Tumor necrosis factor receptor 1 is an ATPase regulated by silencer of death domain.

Authors:  Kiyoshi Miki; Edward M Eddy
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

3.  Phospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration.

Authors:  Ying-Jie Guan; Zhe Zhang; Chen Yu; Li Ma; Weiling Hu; Li Xu; Jin-Song Gao; Chun-Shiang Chung; Lijuan Wang; Zhong-Fa Yang; Loren D Fast; Alicia S Chung; Minsoo Kim; Alfred Ayala; Shougang Zhuang; Shusen Zheng; Y Eugene Chin
Journal:  J Immunol       Date:  2011-07-01       Impact factor: 5.422

4.  TNF receptor-1 (TNF-R1) ubiquitous scaffolding and signaling protein interacts with TNF-R1 and TRAF2 via an N-terminal docking interface.

Authors:  Jennifer L Terry Powers; Kimberly E Mace; Helen Parfrey; Shin-Je Lee; Gongyi Zhang; David W H Riches
Journal:  Biochemistry       Date:  2010-09-14       Impact factor: 3.162

5.  TRUSS, a novel tumor necrosis factor receptor 1 scaffolding protein that mediates activation of the transcription factor NF-kappaB.

Authors:  Surinder M Soond; Jennifer L Terry; Jeff D Colbert; David W H Riches
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.